...
首页> 外文期刊>International Journal of Pharmaceutics >Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.
【24h】

Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.

机译:双膦酸盐靶向脂质体的骨靶向潜力。体外制备,表征和羟基磷灰石结合。

获取原文
获取原文并翻译 | 示例

摘要

The main constituent of bone is hydroxyapatite (HAP). Since HAP is only present in 'hard' tissues like bone and teeth, it represents a promising target for the selective drug delivery to bone. Due to the exceptional affinity of bisphosphonates (BP) for HAP, cholesteryl-trisoxyethylene-bisphosphonic acid (CHOL-TOE-BP), a new tailor-made BP derivative, was used as bone targeting moiety for liposomes. CHOL-TOE-BP-targeted liposomes were designed for the treatment of bone-related diseases to achieve prolonged local exposure to high concentrations of the bioactive compounds, thereby enhancing therapeutic efficacy and minimizing systemic side effects. The CHOL-TOE-BP-targeted liposomes were characterized regarding particle size and zeta potential. To study the bone targeting potential of these conjugates, an in vitro HAP binding assay was established. The obtained binding data indicate that CHOL-TOE-BP is useful as targeting device for liposomal drug delivery to bone.
机译:骨骼的主要成分是羟磷灰石(HAP)。由于HAP仅存在于“硬”组织(如骨骼和牙齿)中,因此它代表了选择性药物向骨骼的递送的有希望的目标。由于双膦酸酯(BP)对HAP具有非凡的亲和力,因此,新的量身定制的BP衍生物胆甾醇三氧乙烯双膦酸(CHOL-TOE-BP)被用作脂质体的骨靶向部分。将CHOL-TOE-BP靶向的脂质体设计用于治疗骨相关疾病,以实现长时间局部暴露于高浓度的生物活性化合物,从而增强治疗效果并最大程度地减少全身性副作用。针对CHOL-TOE-BP靶向的脂质体的粒径和ζ电位进行了表征。为了研究这些结合物的骨靶向潜力,建立了体外HAP结合测定。获得的结合数据表明CHOL-TOE-BP可用作脂质体药物递送至骨的靶向装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号